Published in JAMA on July 23, 1973
Medical preparation for travel in Africa. J Natl Med Assoc (1982) 1.39
The crucial role of metal ions in neurodegeneration: the basis for a promising therapeutic strategy. Br J Pharmacol (2005) 1.32
Interventions for the control of diarrhoeal diseases among young children: chemoprophylaxis. Bull World Health Organ (1985) 1.03
Clioquinol-zinc chelate: a candidate causative agent of subacute myelo-optic neuropathy. Mol Med (1998) 1.01
Mapping brain metals to evaluate therapies for neurodegenerative disease. CNS Neurosci Ther (2010) 0.91
Iodochlorhydroxyquin and optic nerve damage. Can Med Assoc J (1977) 0.77
Some aspects of medical management of gastrointestinal disease. Part II. Can Med Assoc J (1975) 0.75
Congenital malformations surveillance: two American systems. Int J Epidemiol (1981) 2.58
Eat right and take a multivitamin. N Engl J Med (1998) 2.38
A multiple-source method for studying the prevalence of developmental disabilities in children: the Metropolitan Atlanta Developmental Disabilities Study. Pediatrics (1992) 2.32
5,10 Methylenetetrahydrofolate reductase genetic polymorphism as a risk factor for neural tube defects. Am J Med Genet (1996) 1.68
Hormonal pregnancy tests and congenital malformations. Lancet (1973) 1.68
Teratogen update: valproic acid. Teratology (1987) 1.68
Let's increase folic acid fortification and include vitamin B-12. Am J Clin Nutr (1997) 1.63
Down's syndrome. Recent trends in the United States. JAMA (1981) 1.61
Association between cleft lip with or without cleft palate and prenatal exposure to diazepam. Lancet (1975) 1.51
Urgent need to increase folic acid consumption. JAMA (1995) 1.43
Vitamin A and birth defects. Continuing caution is needed. N Engl J Med (1995) 1.41
Maternal serum alpha-fetoprotein screening: a cost-benefit analysis. Am J Public Health (1979) 1.41
Utilization of prenatal genetic diagnosis in women 35 years of age and older in the United States, 1977 to 1978. Am J Obstet Gynecol (1981) 1.28
Teratology Society Consensus Statement on use of folic acid to reduce the risk of birth defects. Teratology (1997) 1.19
Genetic services in the United States. JAMA (1982) 1.12
Is Bendectin a teratogen? JAMA (1981) 1.09
Congenital hypothyroidism control programs. A cost-benefit analysis. JAMA (1979) 0.99
Natural selection, selection bias and the prevalence of Down's syndrome. N Engl J Med (1978) 0.99
Prenatal chromosomal diagnosis. Racial and geographic variation for older women in Georgia. JAMA (1980) 0.96
Population and case-control surveillance in the search for environmental causes of birth defects. Public Health Rep (1984) 0.94
The rôle of birth defect surveillance in control of fetal enviromental hazards. Postgrad Med J (1975) 0.90
Spray adhesives and birth defects. JAMA (1976) 0.90
Estimates of birth prevalence rates of spina bifida in the United States from computer-generated maps. Am J Obstet Gynecol (1983) 0.89
Folic acid-preventable spina bifida and anencephaly. JAMA (1993) 0.89
The unnecessary epidemic of folic acid-preventable spina bifida and anencephaly. Pediatrics (2000) 0.88
Tocolytic magnesium sulfate exposure and risk of cerebral palsy among children with birth weights less than 1,750 grams. Am J Epidemiol (2000) 0.87
Survival of infants with spina bifida--Atlanta, 1972-1979. Am J Dis Child (1985) 0.86
Water fluoridation and congenital malformations: no association. J Am Dent Assoc (1976) 0.85
Maternal age and births in the 1980s. JAMA (1982) 0.85
Frequency of human congenital malformations. Clin Perinatol (1986) 0.84
Failed intrauterine device contraception and limb reduction deformities: a case-control study. Fertil Steril (1979) 0.82
Vitamins and neural tube defects. Lancet (1983) 0.81
Descriptive epidemiology of small-bowel atresia in metropolitan Atlanta. Teratology (1976) 0.80
Clinical interpretation of maternal serum alpha-fetoprotein concentrations. Am J Obstet Gynecol (1984) 0.80
Drug exposure during pregnancy: some epidemiologic considerations. Clin Obstet Gynecol (1983) 0.80
Folic acid fortification. Lancet (2000) 0.79
Letter: Alpha-fetoprotein as predictor of fetal neural-tube defects. Lancet (1975) 0.79
Prevention of neural-tube defects. N Engl J Med (1999) 0.77
Minimum fully effective dose of folic acid for the prevention of neural tube defects. Epidemiology (2001) 0.77
Periconceptional intake of folic acid among low-income women. JAMA (2000) 0.77
Letter: Haloperidol and limb deformity. JAMA (1975) 0.77
Reducing birth defect risk in advanced maternal age. JAMA (1979) 0.76
Valium: an oral cleft teratogen? Cleft Palate J (1976) 0.76
Trends in clinical characteristics of infants with spina bifida--Atlanta, 1972-1979. Am J Dis Child (1985) 0.76
Incidence of Down syndrome. Am J Hum Genet (1987) 0.75
Rh hemolytic disease of the newborn: using incidence observations to evaluate the use of RH immune globulin. Am J Public Health (1981) 0.75
Folic acid fortification. N Engl J Med (1999) 0.75
Bad policy, worse medicine. Pediatrics (2000) 0.75
Causal inference in teratology. Prog Clin Biol Res (1980) 0.75
Birth defect surveillance in the search for and evaluation of possible human teratogens. J Environ Pathol Toxicol (1979) 0.75
Antenatal diagnosis: potential for major reduction in pediatric morbidity. Pediatr Ann (1981) 0.75
Use of prenatal diagnosis among parents of infants with spina bifida in Atlanta, Georgia, 1976-1979. Am J Obstet Gynecol (1984) 0.75
Anencephaly in Chile. Lancet (1973) 0.75
Birth defects epidemiology and surveillance. Prog Clin Biol Res (1985) 0.75
Birth defect surveillance in the search for and evaluation of possible human teratogens. Birth Defects Orig Artic Ser (1976) 0.75
Spermicides and birth defects. JAMA (1982) 0.75
Interpreting elevated amniotic fluid alpha-fetoprotein levels in clinical practice: use of the predictive value positive concept. Am J Obstet Gynecol (1979) 0.75
Temporal trends in reported malformation incidence for the United States--Birth Defects Monitoring Program. Morb Mortal Wkly Rep Surveill Summ (1983) 0.75
Prenatal diagnosis of pericentric inversion of chromosome No. 17 in a twin pregnancy. Prenat Diagn (1984) 0.75
Drug influences on malformations. Clin Perinatol (1979) 0.75
Temporal trends in reported malformation incidence for the United States--Birth Defects Monitoring Program. Clin Pediatr (Phila) (1984) 0.75
Threatened abortion, hormone therapy and malformed embryos. Teratology (1979) 0.75
Population and case-control surveillance in the search for environmental causes of birth defects. Prog Clin Biol Res (1985) 0.75
Seizure disorder in mothers of children with orofacial clefts: a case-control study. J Pediatr (1974) 0.75